| 28/09/2021 |
Department of Health and Human Services - Office of Assistant Secretary for Preparedness and Response
|
ESTABLISHMENT OF HIGH THROUGHPUT SARS-COV-2 BINDING ANTIBODY IMMUNOASSAY CAPABILITY AND TESTING OF HUMAN SERUM SAMPLES: MODIFIED TO REMOVE REQUIREMENTS AND FUNDING |
-689 732 USD |
FIRM FIXED PRICE |
| 24/09/2021 |
Department of Health and Human Services - National Institutes of Health
|
"COVID-19". TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL. ALSO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVIC... |
-269 864 USD |
COST PLUS AWARD FEE |
| 23/09/2021 |
Department of Health and Human Services - National Institutes of Health
|
CLINICAL SITE AND STUDY MONITORING FOR RESEARCH PARTNERSHIPS FOR GLOBAL MENTAL HEALTH. |
0 USD |
LABOR HOURS |
| 10/09/2021 |
Department of Health and Human Services - National Institutes of Health
|
KENNY-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19302 (AZD4041) |
0 USD |
COST PLUS FIXED FEE |
| 07/09/2021 |
Department of Health and Human Services - National Institutes of Health
|
EXPLORATORY MSD ECL OR SMC ANALYSIS OF PROGERIN IN MOUSE TISSUE SAMPLES |
61 800 USD |
FIRM FIXED PRICE |
| 07/09/2021 |
Department of Health and Human Services - National Institutes of Health
|
NIAID/DCR TECHNICAL AND ADMINISTRATIVE MANAGEMENT SERVICES |
0 USD |
ORDER DEPENDENT (IDV ALLOWS PRICING ARRANGEMENT TO |
| 30/08/2021 |
Department of Health and Human Services - National Institutes of Health
|
COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS |
0 USD |
FIRM FIXED PRICE |
| 30/08/2021 |
Department of Health and Human Services - National Institutes of Health
|
COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS |
2 000 USD |
FIRM FIXED PRICE |
| 20/08/2021 |
Department of Health and Human Services - National Institutes of Health
|
KENNY-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19302 (AZD4041) |
0 USD |
COST PLUS FIXED FEE |
| 16/08/2021 |
Department of Health and Human Services - National Institutes of Health
|
REGULATORY MANAGEMENT CENTER |
330 811 USD |
COST PLUS FIXED FEE |
| 13/08/2021 |
Department of Health and Human Services - National Institutes of Health
|
CLINICAL SITE AND STUDY MONITORING FOR RESEARCH PARTNERSHIPS FOR GLOBAL MENTAL HEALTH. |
178 010 USD |
LABOR HOURS |
| 11/08/2021 |
Department of Health and Human Services - National Institutes of Health
|
"COVID-19". TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL. ALSO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVIC... |
291 508 796 USD |
COST PLUS AWARD FEE |
| 04/08/2021 |
Department of Health and Human Services - National Institutes of Health
|
BUCKPITT-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19186 (EC5026): NO-COST EXTENSION THROUGH 10/31/2021, COST OVERRUN & COR/ALTERNATE CHANGE |
0 USD |
COST PLUS FIXED FEE |
| 31/07/2021 |
Department of Defense - Department of the Army
|
TRAINING - FDA |
19 381 USD |
FIRM FIXED PRICE |
| 29/07/2021 |
Department of Defense - Department of the Army
|
OPTION 1 - TRAINING |
-10 000 USD |
FIRM FIXED PRICE |
| 27/07/2021 |
Department of Defense - Department of the Army
|
EXERCISE OPTION 2 FOR MEDICAL PRODUCT RESEARCH AND DEVELOPMENT |
0 USD |
ORDER DEPENDENT (IDV ALLOWS PRICING ARRANGEMENT TO |
| 19/07/2021 |
Department of Defense - Department of the Army
|
THIS REQUIREMENT IS FOR THE MONITORING OF PHASE 2B HIV STUDY |
841 420 USD |
COST PLUS FIXED FEE |
| 15/07/2021 |
Department of Health and Human Services - National Institutes of Health
|
"COVID-19". TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL. |
-36 187 451 USD |
COST PLUS AWARD FEE |
| 06/07/2021 |
Department of Health and Human Services - Office of Assistant Secretary for Preparedness and Response
|
ESTABLISHMENT OF HIGH THROUGHPUT SARS-COV-2 BINDING ANTIBODY IMMUNOASSAY CAPABILITY AND TESTING OF HUMAN SERUM SAMPLES: MODIFIED TO REMOVE THE REQUIREMENT TO TEST A BATCH OF SERA SAMPLES |
-637 813 USD |
FIRM FIXED PRICE |
| 30/06/2021 |
Department of Health and Human Services - National Institutes of Health
|
ID/IQ PARENT AWARD FOR PHASE I CLINICAL TRIALS FOR DEVELOPMENT OF NEUROTHERAPEUTICS |
0 USD |
COST PLUS FIXED FEE |